|
 | Up a level |
Kar, A and Medatwal, N and Rajput, K and Mandal, S and Pani, T and Khan, A and Sharma, P and Oberoi, AS and Vishwakarma, G and Deo, SVS and Jolly, MK and Bajaj, A and Dasgupta, U (2023) Unique sphingolipid signature identifies luminal and triple-negative breast cancer subtypes. In: International Journal of Cancer .
Roy, U and Raghavan, SC (2021) Deleterious point mutations in T-cell acute lymphoblastic leukemia: Mechanistic insights into leukemogenesis. In: International Journal of Cancer .
Rakshit, Srabanti and Ponnusamy, Manikandan and Papanna, Sumitha and Saha, Banishree and Ahmed, Asma and Nandi, Dipankar (2012) Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: Critical roles of IFN gamma. In: International Journal of Cancer, 130 (4). pp. 865-875.
Kothari, Vishal and Joshi, Ganesh and Nama, Srikanth and Somasundaram, Kumaravel and Mulherkar, Rita (2010) HDAC inhibitor valproic acid enhances tumor cell kill in adenovirus-HSVtk mediated suicide gene therapy in HNSCC xenograft mouse model. In: International Journal of Cancer, 126 (3). pp. 733-742.
Joseph, Jeena and Wajapeyee, Narendra and Somasundaram, Kumaravel (2005) Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate. In: International Journal of Cancer, 115 (1). pp. 11-18.
Karande, Anjali A and Sridhar, Lakshmi and Gopinath, KS and Adiga, Radhakantha P (2001) Riboflavin Carrier Protein: A Serum and Tissue Marker for Breast Carcinoma. In: International Journal of Cancer, 95 (5). pp. 277-281.
